CAS RN: 1802661-73-9
ONO-8590580
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥99% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260308
5mg / 10mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1802661-73-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1802661-73-9 / 3-(cyclopropylmethyl)-6-fluoro-7-methyl-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]benzimidazol-5-amine
Standard CAS: 1802661-73-9
Multi CAS: No
Basic Information
copy
CAS
1802661-73-9 copy
Multi CAS
No copy
Molecular Formula
C21H21FN6 copy
Molecular Weight
376.400000 copy
Exact Mass
376.181173 copy
SMILES
CC1=C(C(=CC2=C1N=CN2CC3CC3)NC4=NC=C(C=C4)C5=CN(C=N5)C)F copy
InChI
InChI=1S/C21H21FN6/c1-13-20(22)16(7-18-21(13)25-12-28(18)9-14-3-4-14)26-19-6-5-15(8-23-19)17-10-27(2)11-24-17/h5-8,10-12,14H,3-4,9H2,1-2H3,(H,23,26) copy
InChIKey
INGJMHPGMVUEKY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
28 copy
Aromatic heavy atom count
20 copy
Fraction Csp3
0.29 copy
Rotatable bonds
5 copy
H-bond acceptors
6 copy
H-bond donors
1 copy
Molar refractivity
106.87 copy
TPSA
60.56 copy
LogP / Solubility
WLOGP
4.43 copy
MLOGP
3.92 copy
XLogP3
3.1 copy
Consensus LogP
3.82 copy
Log S (ESOL)
-5.17 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.85 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-6.39 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.87 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy